Qiupiao Ling Pian (巯嘌呤片)巯嘌呤片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江奥托康制药集团股份有限公司Chinese legal name: 浙江奥托康制药集团股份有限公司
主要成分Active Ingredients
- 巯嘌呤Qiupiao Ling
药物知识说明
巯嘌呤是一种在国家药监局注册认定的药品。该药品含有巯嘌呤-34aec1ee等成分。
该药品关联的活性成分包括：巯嘌呤Qiupiao Ling。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：浙江奥托康制药集团股份有限公司Chinese legal name: 浙江奥托康制药集团股份有限公司。
您可以探索含有相同成分的其他药品：巯嘌呤-34aec1ee成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 巯嘌呤片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 巯嘌呤Qiupiao Ling.
Manufacturers recorded for this product: 浙江奥托康制药集团股份有限公司Chinese legal name: 浙江奥托康制药集团股份有限公司.
Explore other medicines containing the same ingredient: 巯嘌呤 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 巯嘌呤片Recorded Chinese name: 巯嘌呤片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 50mg50 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 浙江奥托康制药集团股份有限公司Chinese legal name: 浙江奥托康制药集团股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H33020294
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H33020294
Manufacturer
Chinese legal name: 浙江奥托康制药集团股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H33020294
生产企业
浙江奥托康制药集团股份有限公司(国产)
适应症
本品适用于绒毛膜上皮癌，恶性葡萄胎，急性淋巴细胞白血病及急性非淋巴细胞白血病，慢性粒细胞白血病的急变期。
用法用量
口服给药：|1.绒毛膜上皮癌：成人常用量、每日6mg～6.5mg/kg?分两次口服、以10日为一疗程、疗程间歇为3～4周。|2.白血病：|(1)开始、每日2.5mg/kg或80～100mg/m2?一日1次或分次服用、一般于用药后2～4周可见显效、如用药4周后、仍未见临床改进及白细胞数下降、可考虑在仔细观察下、加量至每日5mg/kg;|(2)维持、每日1.5mg～2.5mg/kg或5ｏmg～100mg/m2?一日1次或分次口服。
不良反应
1. 较常见的为骨髓抑制:可有白细胞及血小板减少;|2. 肝脏损害:可致胆汁郁积出现黄疸;|3. 消化系统:恶心，呕吐，食欲减退，口腔炎，腹泻、但较少发生、可见于服药量过大的患者。|4. 高尿酸血症:多见于白血病治疗初期、严重的可发生尿酸性肾病;|5. 间质性肺炎及肺纤维化少见。
禁忌
已知对本品高度过敏的患者禁用。
注意事项
1. 对诊断的干扰：白血病时有大量白血病细胞破坏、在服本品时则破坏更多、致使血液及尿中尿酸浓度明显增高、严重者可产生尿酸盐肾结石。|2. 下列情况应慎用：骨髓已有显著的抑制现象?(白细胞减少或血小板显著降低)或出现相应的严重感染或明显的出血倾向;肝功能损害、胆道疾患者、有痛风病史、尿酸盐肾结石病史者;4～6周内已接受过细胞毒药物或放射治疗者。|3. 用药期间应注意定期检查外周血象及肝、肾功能、每周应随访白细胞计数及分类、血小板计数、血红蛋白1～2次、对血细胞在短期内急骤下降者、应每日观察血象。
贮藏
遮光，密闭保存。
规格
50mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.